Media stories about VirtualScopics (NASDAQ:VSCP) have trended somewhat positive this week, according to AlphaOne Sentiment. The research group, a service of Accern, rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. AlphaOne ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. VirtualScopics earned a media sentiment score of 0.12 on AlphaOne’s scale. AlphaOne also gave news coverage about the medical equipment provider an impact score of 83 out of 100, indicating that recent press coverage is very likely to have an impact on the company’s share price in the immediate future.

Shares of VirtualScopics (NASDAQ:VSCP) remained flat at $4.04 during trading on Friday. The stock’s 50 day moving average is $4.05 and its 200 day moving average is $3.54. VirtualScopics has a 12 month low of $1.73 and a 12 month high of $6.65.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive Media Coverage Very Likely to Affect VirtualScopics (VSCP) Share Price” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/04/21/somewhat-positive-media-coverage-very-likely-to-affect-virtualscopics-vscp-share-price.html.



VirtualScopics Company Profile

VirtualScopics, Inc is a provider of imaging services serving the pharmaceutical and biotechnology industries in early and late-stage clinical trials. The Company offers a range of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images.

5 Day Chart for NASDAQ:VSCP

Receive News & Stock Ratings for VirtualScopics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VirtualScopics Inc and related stocks with our FREE daily email newsletter.